The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters from Pfizer, Moderna and Novavax.
Drug developer Arvinas said on Wednesday it will grant commercialization rights of an experimental breast cancer treatment it was developing with Pfizer to a third party.

5 Best High-Yield Dividend Stocks to Buy Now

05:45am, Wednesday, 17'th Sep 2025
High-yield dividend stocks entice investors with payouts two to four times higher than the S&P 500's 1.4% average yield. But high yield often signals trouble -- sluggish growth, stretched payout ratio
The S&P 500 is offering a skinny yield of 1.2%. The average healthcare stock has a yield of 1.7%.
Need investment income? Dividend stocks are an obvious option to consider.
MRNA, BNTX, PFE and NVAX stocks fall as health officials reportedly plan to link COVID-19 vaccines to child deaths ahead of a key CDC meeting.
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
If you're a long-term investor, why should you be paying closer attention to pharmaceutical giant Pfizer (PFE -3.98%)? Because of its dividend, of course!
Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively.
Sixteen of the thirty-eight highest-yield, 'safer' S&P 500 dividend stocks are highlighted as ready to buy, with adequate free cash flow supporting payouts. Analyst forecasts suggest top ten S&P 500 d
Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.
Shares of Pfizer and Moderna fell on Friday after a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children.  The report comes as Health and Human S
CNBC's Angelica Peebles joins 'Money Movers' to discuss Trump officials reported plan to link child deaths to covid shots.
Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.

Why Pfizer (PFE) Outpaced the Stock Market Today

06:45pm, Thursday, 11'th Sep 2025
In the most recent trading session, Pfizer (PFE) closed at $24.83, indicating a +1.04% shift from the previous trading day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE